Recurrence of Trigeminal Neuralgia in Patient's Undergoing Radiofrequency Ablation
Recurrence Rate of Trigeminal Neuralgia in Patients Treated With Percutaneous Stereotactic Continuous Radiofrequency Rhizotomy at 80 Degrees Celsius for 90 Seconds- a Single Center Study.
1 other identifier
observational
56
0 countries
N/A
Brief Summary
This study aims to find recurrence rate of the trigeminal neuralgia after patients undergo stereotactic rhizotomy by radiofrequency ablation at 80 degrees Celsius for 90 seconds under fluoroscopic guidance, a protocol that was modified from the originally described parameters for rhizotomy by John Tew, Chad J. Morgan and Andresw Grande et al. The presumption being that the higher temperature of the probe tip would lead to a more long-lasting lesion and lesser recurrence, but at the cost of more frequent sensory and motor deficits.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2016
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 20, 2021
CompletedFirst Submitted
Initial submission to the registry
October 28, 2021
CompletedFirst Posted
Study publicly available on registry
November 1, 2021
CompletedNovember 1, 2021
October 1, 2021
5 years
October 28, 2021
October 28, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Recurrence rate of trigeminal neuralgia after stereotactic rhizotomy
Recurrence of pain in the same distribution of the trigeminal nerve branch or branches for which the stereotactic rhizotomy was originally performed
Recurrence within 12 months of the intervention
Proportion of patients with neurological deficits after stereotactic rhizotomy
locally deviced protocol for stereotactic rhizotomy of the involved trigeminal gangion dictates the use of higher temperature of 80 degree Celsius for 90 seconds, which translates into better pain relief and longer pain free intervals at the cost of higher percentage of sensory and motor deficits
5 years
Eligibility Criteria
Adult patients of all genders presenting to Pain Clinic, referred of otherwise, diagnosed to have trigeminal neuralgia without concomitant central nervous pathologies including space occupying lesions, vascular and auto-immune disorders, who were planned for stereotactic rhizotomy under deep sedation and monitored anesthesia care as daycare cases.
You may qualify if:
- \. Patients fulfilling ICHD criteria:
- Recurrent paroxysms of unilateral facial pain in the distribution(s) of one or more divisions of the trigeminal nerve, with no radiation beyond, and fulfilling criteria B and C
- A. Pain has all of the following characteristics:
- lasting from a fraction of a second to 2 minutes
- severe intensity
- electric shock-like, shooting, stabbing or sharp in quality B. Precipitated by innocuous stimuli within the affected trigeminal distribution C. Not better accounted for by another ICHD-3 diagnosis.
- \. Age: Adults of both sexes 3. MRI brain ruled out organic or structural pathologies
You may not qualify if:
- \. Patient with concomitant co-morbid conditions like brain tumours, vascular pathologies or coagulopathies.
- \. Patients who had previously undergone trigeminal ganglion neurolysis with either alcohol or phenol.
- \. Patients who were lost to follow-up before the completion of 6-month period or had not visited back after the procedure 4. Patients on oral anticoagulants 5. Patients declared high risk or ASA 3 and above for general anaesthesia.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (5)
Taha JM, Tew JM Jr, Buncher CR. A prospective 15-year follow up of 154 consecutive patients with trigeminal neuralgia treated by percutaneous stereotactic radiofrequency thermal rhizotomy. J Neurosurg. 1995 Dec;83(6):989-93. doi: 10.3171/jns.1995.83.6.0989.
PMID: 7490643BACKGROUNDRashid A, Pintea B, Kinfe TM, Surber G, Hamm K, Bostrom JP. LINAC stereotactic radiosurgery for trigeminal neuralgia -retrospective two-institutional examination of treatment outcomes. Radiat Oncol. 2018 Aug 22;13(1):153. doi: 10.1186/s13014-018-1102-2.
PMID: 30134992BACKGROUNDKao CH, Lee MH, Yang JT, Tsai YH, Lin MH. Percutaneous Radiofrequency Rhizotomy Is Equally Effective for Trigeminal Neuralgia Patients with or Without Neurovascular Compression. Pain Med. 2022 Apr 8;23(4):807-814. doi: 10.1093/pm/pnab221.
PMID: 34264315BACKGROUNDZhao G, Sun X, Zhang Z, Yang H, Zheng X, Feng B. Clinical efficacy of MVD combined with PSR in the treatment of primary trigeminal neuralgia. Exp Ther Med. 2020 Aug;20(2):1582-1588. doi: 10.3892/etm.2020.8871. Epub 2020 Jun 10.
PMID: 32742390BACKGROUNDElnashar A, Patel SK, Kurbanov A, Zvereva K, Keller JT, Grande AW. Comprehensive anatomy of the foramen ovale critical to percutaneous stereotactic radiofrequency rhizotomy: cadaveric study of dry skulls. J Neurosurg. 2019 Apr 19;132(5):1414-1422. doi: 10.3171/2019.1.JNS18899. Print 2020 May 1.
PMID: 31003215BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Salman A. Saleem, MBBS;FCPS
Shifa Clinical Research Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Fellow Pain Medicine
Study Record Dates
First Submitted
October 28, 2021
First Posted
November 1, 2021
Study Start
September 1, 2016
Primary Completion
August 31, 2021
Study Completion
October 20, 2021
Last Updated
November 1, 2021
Record last verified: 2021-10